Literature DB >> 33124561

The frequency and clinical course of COVID-19 infection in children with juvenile idiopathic arthritis.

Mehmet Yildiz1, Fatih Haslak1, Amra Adrovic1, Sezgin Sahin1, Kenan Barut1, Ozgur Kasapcopur2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33124561

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  5 in total

1.  COVID-19 Vaccination Intention and Vaccine Hesitancy among Patients with Autoimmune and Autoinflammatory Rheumatological Diseases: A Survey.

Authors:  Samar Tharwat; Haidy Adel Abdelsalam; Adel Abdelsalam; Mohammed Kamal Nassar
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

2.  Optimal biologics for juvenile idiopathic arthritis in an infection with SARS-CoV-2 α-variant.

Authors:  Shunichi Adachi; Motoshi Sonoda; Masataka Ishimura; Katsuhide Eguchi; Tamami Tanaka; Yoshitomo Motomura; Shouichi Ohga
Journal:  Pediatr Allergy Immunol       Date:  2021-11-06       Impact factor: 5.464

3.  A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property.

Authors:  Özgür Kasapçopur
Journal:  Turk Arch Pediatr       Date:  2021-07-01

4.  Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children.

Authors:  Fatih Haslak; Sevki Erdem Varol; Aybuke Gunalp; Ozge Kaynar; Mehmet Yildiz; Amra Adrovic; Sezgin Sahin; Gulsen Kes; Ayse Ayzit-Kilinc; Beste Akdeniz; Pinar Onal; Gozde Apaydin; Deniz Aygun; Huseyin Arslan; Azer Kilic-Baskan; Evrim Hepkaya; Ozge Meral; Kenan Barut; Haluk Cezmi Cokugras; Ozgur Kasapcopur
Journal:  J Clin Med       Date:  2022-04-09       Impact factor: 4.964

5.  Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children.

Authors:  Fatih Haslak; Dogukan Ozbey; Mehmet Yildiz; Amra Adrovic; Sezgin Sahin; Oya Koker; Ayten Aliyeva; Vafa Guliyeva; Gamze Yalcin; Gulmelek Inanli; Bekir S Kocazeybek; Ozgur Kasapcopur; Kenan Barut
Journal:  Clin Rheumatol       Date:  2022-01-19       Impact factor: 3.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.